Mark D. Rosen
Impact in
- Organic Chemistry top 10%
- Asymmetric Synthesis and Catalysis
- Synthetic Organic Chemistry Methods
- Catalytic C–H Functionalization Methods
- Chemical synthesis and alkaloids
- Synthesis and Catalytic Reactions
- Advanced Synthetic Organic Chemistry
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Metabolomics and Mass Spectrometry Studies 3
- Chemical Synthesis and Analysis 2
- RNA regulation and disease 2
-
- Synthetic Organic Chemistry Methods 4
- Co-authors
- Larry E. Overman (4 shared papers)Michael H. Rabinowitz (9 shared papers)Lothar Schwink (1 shared paper)Terrance D. Barrett (8 shared papers)Jeremy P. Scott (1 shared paper)Kimon C. Kanelakis (6 shared papers)Nigel P. Shankley (6 shared papers)Hariharan Venkatesan (5 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (2 papers)Tetrahedron (1 paper)Antioxidants and Redox Signaling (1 paper)Molecular Pharmacology (1 paper)ACS Omega (1 paper)
- Partner nations
- United StatesBelgiumSpain
In The Last Decade
Mark D. Rosen
16 papers receiving 600 citations
Peers
Comparison fields: 5 of 70
- Organic Chemistry 321
- Cancer Research 107
- Pharmacology 44
- Biochemistry 28
- Hematology 41
Countries citing papers authored by Mark D. Rosen
This map shows the geographic impact of Mark D. Rosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Rosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Rosen more than expected).
Fields of papers citing papers by Mark D. Rosen
This network shows the impact of papers produced by Mark D. Rosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Rosen. The network helps show where Mark D. Rosen may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark D. Rosen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 144 | |
| 2 | 2003 | 82 | |
| 3 | 2011 | 67 | |
| 4 | 2010 | 55 | |
| 5 | 2000 | 43 | |
| 6 | 2015 | 42 | |
| 7 | 2009 | 35 | |
| 8 | 2010 | 32 | |
| 9 | 2015 | 28 | |
| 10 | 2013 | 26 | |
| 11 | 2009 | 13 | |
| 12 | 2018 | 10 | |
| 13 | 2009 | 8 | |
| 14 | 2007 | 8 | |
| 15 | 2008 | 7 | |
| 16 | 2019 | 6 |
About Mark D. Rosen
Mark D. Rosen is a scholar working on Molecular Biology, Organic Chemistry, Cell Biology, Cancer Research and Cellular and Molecular Neuroscience, having authored 16 papers that have together received 606 indexed citations. Recurring topics across this work include Synthetic Organic Chemistry Methods (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Chemical Synthesis and Analysis (2 papers), RNA regulation and disease (2 papers), Microbial Natural Products and Biosynthesis (2 papers) and Neuropeptides and Animal Physiology (2 papers). The work is most often cited by research in Organic Chemistry (321 citations), Cancer Research (107 citations), Pharmacology (44 citations), Biochemistry (28 citations) and Hematology (41 citations). Mark D. Rosen has collaborated with scholars based in United States, Belgium and Spain. Frequent co-authors include Larry E. Overman, Michael H. Rabinowitz, Lothar Schwink, Terrance D. Barrett, Jeremy P. Scott, Kimon C. Kanelakis, Nigel P. Shankley, Hariharan Venkatesan, Wen Yan and Xiaodong Wu. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron, Antioxidants and Redox Signaling, Molecular Pharmacology and ACS Omega.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.